1-4 of 4
Anita Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A

Alexander Solms, Anita Shah, Sara Wiegmann, Maurice Ahsman, Erik Berntorp, Andreas Tiede, MD, Alfonso Iorio, MDPhD, Maria Elisa Mancuso, Tihomir Zhivkov, Toshko Lissitchkov
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-136586
Published: 2020
Journal Articles

Improved Pharmacokinetic Profile for BAY 81-8973 Due to Increased Branching and Sialylation of N-Linked Glycans of Recombinant Factor VIII

John M. Teare, PhD, David S. Kates, Anita Shah, Stephen Garger
Journal: Blood
Blood (2018) 132 (Supplement 1): 1209.
https://doi.org/10.1182/blood-2018-99-113061
Published: 2018
Journal Articles

Pharmacodynamics, Pharmacokinetics and Safety of Bay 1093884, an Antibody Directed Against Human TFPI, in Patients with Factor VIII or IX Deficiency (With and Without Inhibitors): A Phase 1 Study

Pratima Chowdary, MD, Toshko Jelev Lissitchkov, MD, Stefan Willmann, Dr, Stephan Schwers, PhD, Lisa A. Michaels, Anita Shah
Journal: Blood
Blood (2018) 132 (Supplement 1): 1176.
https://doi.org/10.1182/blood-2018-99-114683
Published: 2018
Journal Articles

New Approach in Assessing the Pharmacokinetic/Pharmacodynamic Relationship in Patients with Severe Hemophilia A Using Data from BAY 81-8973 Studies

Dirk Garmann, Matthias Frede, Anita Shah, Bart Ploeger
Journal: Blood
Blood (2015) 126 (23): 1095.
https://doi.org/10.1182/blood.V126.23.1095.1095
Published: 2015